Biogen to Pay $22 Million to Resolve US  Drug Charity Kickback Probe Biogen to Pay $22 Million to Resolve US  Drug Charity Kickback Probe

Biogen Inc has agreed to pay $22 million to resolve US allegations that it illegally used two charities that help cover Medicare patients ' out-of-pocket drug costs as a means to pay them kickbacks to use its multiple sclerosis drugs.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news